Vonoprazan fumarate
- $43 - $2348
- Product name: Vonoprazan fumarate
- CAS: 1260141-27-2
- MF: C21H20FN3O6S
- MW: 461.4634032
- EINECS:250-635-4
- MDL Number:MFCD18633280
- Synonyms:1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine;AK-438;vonoprazan(tak-438);fuMarate vonoprazan;1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, 2-butenedioate (1:1);5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate TAK 438;vonaprazan(TK-438);TAK-438 Vonoprazan fumarate
17 prices
Selected condition:
Brand
- AK Scientific
- ApexBio Technology
- Biosynth Carbosynth
- Cayman Chemical
- Chemenu
- Crysdot
- DC Chemicals
- Matrix Scientific
- Usbiological
Package
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 5g
- 10g
- ManufacturerAK Scientific
- Product numberJ97352
- Product descriptionTAK-438
- Packaging5g
- Price$315
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberA2308
- Product descriptionTAK-438
- Packaging5mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberA2308
- Product descriptionTAK-438
- Packaging25mg
- Price$600
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFT102406
- Product descriptionTAK 438
- Packaging10mg
- Price$225
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFT102406
- Product descriptionTAK 438
- Packaging50mg
- Price$787.5
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number24200
- Product descriptionVonoprazan (fumarate) ≥98%
- Packaging500mg
- Price$43
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number24200
- Product descriptionVonoprazan (fumarate) ≥98%
- Packaging1g
- Price$76
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number24200
- Product descriptionVonoprazan (fumarate) ≥98%
- Packaging5g
- Price$293
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number24200
- Product descriptionVonoprazan (fumarate) ≥98%
- Packaging10g
- Price$417
- Updated2023-06-20
- Buy
- ManufacturerChemenu
- Product numberCM176408
- Product description1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanaminefumarate 97%
- Packaging100mg
- Price$1257
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD31004062
- Product descriptionTAK-438 98+%
- Packaging5mg
- Price$210
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD31004062
- Product descriptionTAK-438 98+%
- Packaging10mg
- Price$278
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD31004062
- Product descriptionTAK-438 98+%
- Packaging25mg
- Price$435
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDC7306
- Product descriptionTAK-438 >98%
- Packaging250mg
- Price$500
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number145190
- Product description1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate 95%
- Packaging100mg
- Price$1305
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number145190
- Product description1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate 95%
- Packaging250mg
- Price$2348
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | J97352 | TAK-438 | 5g | $315 | 2021-12-16 | Buy |
ApexBio Technology | A2308 | TAK-438 | 5mg | $200 | 2021-12-16 | Buy |
ApexBio Technology | A2308 | TAK-438 | 25mg | $600 | 2021-12-16 | Buy |
Biosynth Carbosynth | FT102406 | TAK 438 | 10mg | $225 | 2021-12-16 | Buy |
Biosynth Carbosynth | FT102406 | TAK 438 | 50mg | $787.5 | 2021-12-16 | Buy |
Cayman Chemical | 24200 | Vonoprazan (fumarate) ≥98% | 500mg | $43 | 2023-06-20 | Buy |
Cayman Chemical | 24200 | Vonoprazan (fumarate) ≥98% | 1g | $76 | 2023-06-20 | Buy |
Cayman Chemical | 24200 | Vonoprazan (fumarate) ≥98% | 5g | $293 | 2023-06-20 | Buy |
Cayman Chemical | 24200 | Vonoprazan (fumarate) ≥98% | 10g | $417 | 2023-06-20 | Buy |
Chemenu | CM176408 | 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanaminefumarate 97% | 100mg | $1257 | 2021-12-16 | Buy |
Crysdot | CD31004062 | TAK-438 98+% | 5mg | $210 | 2021-12-16 | Buy |
Crysdot | CD31004062 | TAK-438 98+% | 10mg | $278 | 2021-12-16 | Buy |
Crysdot | CD31004062 | TAK-438 98+% | 25mg | $435 | 2021-12-16 | Buy |
DC Chemicals | DC7306 | TAK-438 >98% | 250mg | $500 | 2021-12-16 | Buy |
Matrix Scientific | 145190 | 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate 95% | 100mg | $1305 | 2021-12-16 | Buy |
Matrix Scientific | 145190 | 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate 95% | 250mg | $2348 | 2021-12-16 | Buy |
Properties
storage temp. :Store at -20°C
solubility :insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
form :solid
InChIKey :ROGSHYHKHPCCJW-WLHGVMLRSA-N
SMILES :N1(S(C2=CC=CN=C2)(=O)=O)C(C2=CC=CC=C2F)=CC(CNC)=C1.C(O)(=O)/C=C/C(O)=O
solubility :insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
form :solid
InChIKey :ROGSHYHKHPCCJW-WLHGVMLRSA-N
SMILES :N1(S(C2=CC=CN=C2)(=O)=O)C(C2=CC=CC=C2F)=CC(CNC)=C1.C(O)(=O)/C=C/C(O)=O
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Vonoprazan fumarate (Takecab®), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer, duodenal ulcer and reflux esophagitis. Vonoprazan fumarate has a novel mechanism of action called potassium-competitive acid blockers, which competitively inhibit the binding of potassium ions to H+, K+-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. Vonoprazan does not inhibit Na+, K+-ATPase activity even at concentrations 500 times higher than that of their IC50 values against gastric H+, K+-ATPase activity. Furthermore, the drug is unaffected by the gastric secretory state, unlike PPIs.More related product prices
120011-70-3 ETOFIBRATE Fosaprepitant dimeglumine Lansoprazole Pantoprazole R-(+)-Lansoprazole Esomeprazole Trelagliptin Alogliptin benzoate Linagliptin AGOMELATINE 1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- 1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- RESATORVID Omeprazole 3-Pyridinesulfonic acid 2'-Fluoroacetophenone 1268454-23-4 TAK-733 TAK-960Related product price
- 120011-70-3
$5-1970 - ETOFIBRATE
$32-1300 - Fosaprepitant dimeglumine
$5-4990
Suppliers and manufacturers
TAIZHOU YUXIN BIOTECHNOLOGY CO,.LTD
Beijing Hope Pharmaceutical Co., Ltd.